נאזונקס תרסיס לאף

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

MOMETASONE FUROATE 50 MCG/DOSE

Disponible des:

MERCK SHARP & DOHME ISRAEL LTD

Codi ATC:

D07AC13

formulario farmacéutico:

SOLUTION

Vía de administración:

NASAL

Fabricat per:

SCHERING-PLOUGH LAB.NV BELGIUM

Grupo terapéutico:

MOMETASONE

indicaciones terapéuticas:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Data d'autorització:

2013-03-01